Targeted Cancer Therapy Casts Wider Net
Targeting cancer gene mutations has been changing the way non-small cell lung cancer ( NSCLC ) is treated. As scientists learn more about the genetic makeup of tumors, more personalized therapy has become available.
Bringing Online a Second-Line Therapy
After the initial therapy for esophageal cancer fails, patients don’t have many choices. A recent study finds that a second-line therapy could be coming online.
Getting the Best Care for Lung Cancer
In the second of our series on lung cancer, we continue our conversation with one of the nation's experts on the subject. D. Ross Camidge , MD, PhD , is a well-known lung cancer specialist and director of the thoracic oncology clinical program at the University of Colorado.